Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Daiichi Sankyo Venezuela, a subsidiary of Daiichi Sankyo Company, will market products of Ranbaxy Laboratories in Venezuela under the hybrid business model.
Subscribe to our email newsletter
Daiichi Sankyo Venezuela, which has already started the promotion, would begin marketing Ranbaxy products.
Ranbaxy has been marketing its drugs in Venezuela through a local distributor.
With the deal, Daiichi Sankyo is expected to focus on Ranbaxy’s portfolio of medicines to promote the Hybrid Business Model.
Under the hybrid business model, Ranbaxy primarily focuses on generic medicine research both for itself and its parent firm, while the new drug discovery program is undertaken taken up by Daiichi Sankyo.